Dr. Marina Wolf is Professor of Behavioral Neuroscience at Oregon Health & Science University (OHSU). She has been a pioneer in studying the role of neuronal plasticity in drug addiction. Her lab uses animal models to understand why recovering addicts remain vulnerable to drug craving and relapse even after long periods of abstinence. Dr. Wolf received her Ph.D. in Pharmacology from Yale in 1986 and trained as a postdoctoral fellow at the Center for Cell Biology, Sinai Hospital of Detroit. She was Assistant Professor of Psychiatry at Wayne State University before moving to the Chicago Medical School/Rosalind Franklin University of Medicine & Science in 1992 where she rose through the ranks, serving as Chair of Neuroscience from 2003-2018. She moved to OHSU in 2018. Her lab has been continuously supported by NIDA since 1992, including a Merit Award (R37). Dr. Wolf was elected a Fellow of the American Association for the Advancement of Science in 2017 and served as ACNP President in 2019. She is honored to have received awards for research and mentoring including the Julius Axelrod Prize (SfN 2022), the Bernice Grafstein Award for Outstanding Accomplishments in Mentoring (SfN 2024; shared), the Paul Hoch Distinguished Service Award (ACNP 2021), and the Julius Axelrod Mentorship Award (ACNP 2023). She has previously served on many NIH study sections and as a member of the NIDA Advisory Council, the NIH Council of Councils, the NIDA Board of Scientific Counselors, the Scientific Council of the Brain & Behavior Research Foundation, and the American Brain Coalition. She founded a company in 2021 to develop therapeutics to facilitate abstinence in persons recovering from stimulant use disorder.